These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. De Boer MP; Meijer RI; Wijnstok NJ; Jonk AM; Houben AJ; Stehouwer CD; Smulders YM; Eringa EC; Serné EH Microcirculation; 2012 Jan; 19(1):5-18. PubMed ID: 21883642 [TBL] [Abstract][Full Text] [Related]
4. New developments in mechanisms of obesity-induced hypertension: role of adipose tissue. Sharma AM; Engeli S; Pischon T Curr Hypertens Rep; 2001 Apr; 3(2):152-6. PubMed ID: 11276398 [TBL] [Abstract][Full Text] [Related]
5. [Obesity and hypertension. Recent advances in etiopathogenesis]. Cesareo R; Iozzino M; Napolitano C; De Rosa P; De Rosa B; Orsini A Recenti Prog Med; 2007; 98(7-8):398-400. PubMed ID: 17685189 [TBL] [Abstract][Full Text] [Related]
7. Obesity and hypertension: a review. Imam K; Sowers JR Henry Ford Hosp Med J; 1988; 36(2):82-7. PubMed ID: 3068210 [No Abstract] [Full Text] [Related]
14. [Obesity and hypertension: from physiopathology to treatment]. Geronooz I; Krzesinski JM Rev Med Liege; 2000 Oct; 55(10):921-8. PubMed ID: 11244800 [TBL] [Abstract][Full Text] [Related]
15. Adipocytokines in relation to cardiovascular disease. Van de Voorde J; Pauwels B; Boydens C; Decaluwé K Metabolism; 2013 Nov; 62(11):1513-21. PubMed ID: 23866981 [TBL] [Abstract][Full Text] [Related]
16. The emerging biology of adipose tissue in chronic kidney disease: from fat to facts. Axelsson J Nephrol Dial Transplant; 2008 Oct; 23(10):3041-6. PubMed ID: 18632589 [No Abstract] [Full Text] [Related]
17. European Society of Hypertension Working Group on Obesity: background, aims and perspectives. Jordan J; Engeli S; Redon J; Sharma AM; Luft FC; Narkiewicz K; Grassi G; J Hypertens; 2007 Apr; 25(4):897-900. PubMed ID: 17351387 [No Abstract] [Full Text] [Related]
18. [Hypertension in obese patients: Pathophysiology and management]. Girerd X; Hansel B Presse Med; 2009 Apr; 38(4):609-13. PubMed ID: 19233604 [TBL] [Abstract][Full Text] [Related]
19. Obesity, hypertension, and the heart. Good D; Morse SA; Ventura HO; Reisin E J Cardiometab Syndr; 2008; 3(3):168-72. PubMed ID: 18983334 [TBL] [Abstract][Full Text] [Related]
20. [Dysmetabolic symptomatic arterial hypertension and dysmetabolic disease]. Bokarev IN; Shubina OI Klin Med (Mosk); 2009; 87(8):67-71. PubMed ID: 19827536 [No Abstract] [Full Text] [Related] [Next] [New Search]